ArticleJournal of anesthesia2026
Detection of motor pathway suppression by transcranial and transesophageal motor-evoked potentials during thoracic epidural anesthesia.
Article in Journal of anesthesia, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeTranscranial motor-evoked potentials (TcMEPs) are widely used to detect intraoperative spinal motor pathway impairment. We developed a novel transesophageal motor-evoked potentials (TeMEPs) technique that directly stimulates the spinal cord from the esophagus at the lower cervical to upper thoracic level. This study compared the ability of TeMEPs and TcMEPs to detect reversible motor pathway suppression.
methodsTen pigs (25.0 ± 0.6 kg) were anesthetized with propofol and remifentanil. Motor pathway suppression was induced using T9-T10 level thoracic epidural anesthesia. After baseline measurements, 3 mL of 0.2% ropivacaine was administered epidurally, and TcMEPs and TeMEPs were recorded every 6 min for 60 min. Subsequently, 0.375% and 0.75% ropivacaine (3 mL each) were administered at 180-min intervals, with recordings continued every 6 min for 120 min after each dose. Changes in MEP amplitudes relative to baseline were quantified using the inhibitory area under the curve (iAUC), and comparisons were made across concentrations and between modalities.
resultsThoracic epidural anesthesia induced concentration-dependent suppression of MEP amplitudes. TcMEPs exhibited marked suppression in both upper and lower limbs at all concentrations. In contrast, TeMEPs demonstrated pronounced and concentration-dependent suppression in the lower limbs, whereas upper-limb TeMEPs were relatively preserved, even at higher concentrations. iAUC analysis revealed significantly greater overall suppression in TcMEPs compared with TeMEPs, particularly in the upper limbs, whereas lower-limb suppression was comparable between modalities at higher concentrations.
conclusionTeMEPs and TcMEPs assess different levels of the motor pathway and TeMEPs may provide a stable assessment of lower-limb motor pathway impairment.
Indexed as
Identifiers
42118251What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.